ICU-acquired weakness

Area of Science:

• Critical care medicine
• Neurology
• Intensive care unit (ICU) management

Background:

• Acquired neuromuscular disorders, including critical illness polyneuropathy (CIP) and critical illness myopathy (CIM), are highly prevalent in patients requiring prolonged mechanical ventilation and critical care.
• Traditional diagnostic methods involve invasive electrophysiologic investigations and muscle biopsies.
• ICU-acquired weakness is a significant complication, contributing to long-term morbidity in survivors, particularly those with ARDS, and is linked to prolonged ventilator dependence.

Purpose of the Study:

• To review the current understanding of acquired weakness syndromes in the ICU.
• To highlight the shift towards non-invasive bedside assessments for diagnosing these conditions.
• To identify key risk factors associated with the development of ICU-acquired weakness.

Main Methods:

• Review of observational studies focusing on patients receiving critical care support.
• Discussion of diagnostic evolution from invasive techniques (electrophysiology, biopsy) to standardized bedside neuromuscular examinations.
• Multivariate analysis to identify risk factors for ICU-acquired weakness.

Main Results:

• Acquired neuromuscular disorders are extremely common in critically ill patients.
• Bedside neuromuscular examinations are emerging as a viable alternative to invasive diagnostic methods.
• Key risk factors for ICU-acquired weakness include severe systemic inflammation, corticosteroid and neuromuscular blocking agent use, poor glycemic control, and immobility.

Conclusions:

• ICU-acquired weakness is a common and significant syndrome with long-term implications for ARDS survivors.
• Early identification of risk factors is crucial for minimizing the impact of acquired weakness.
• A proactive approach to managing risk factors can potentially reduce ventilator dependence and improve patient outcomes.